Vaso

What Vaso does

Vaso Corporation (formerly Vasomedical, Inc.) is a diversified medical technology company that operates through three distinct business units. VasoMedical designs, manufactures, sells, and services proprietary medical devices — principally EECP (Enhanced External Counterpulsation) therapy systems for non-invasive treatment of angina, cardiogenic shock, acute myocardial infarction, and congestive heart failure, and the BIOX line of ambulatory ECG Holter and blood pressure monitoring systems, including combined Holter/ABPM devices and analysis software. Manufacturing is conducted at the company's China-based facilities (Wuxi) under ISO 13485, ISO 9001, and FDA cGMP compliance, while marketing, sales, and service are managed from Plainview, NY and Wuxi with international distribution through channel partners.

VasoHealthcare serves as the exclusive U.S. sales representative for GE Healthcare diagnostic imaging equipment, a partnership that has been renewed five times since 2010 and most recently extended through December 31, 2030, targeting the healthcare middle market of independent hospitals, imaging centers, and multispecialty clinics. VasoTechnology provides managed IT systems and services — network connectivity, data storage, and security — for enterprises and healthcare customers with mission-critical applications, operating through the NetWolves and (until November 2025) VasoHealthcare IT brands.

The company generates revenue through a mix of capital equipment sales, equipment rentals, and recurring extended service contracts (1-4 year terms), with $38.6 million in deferred revenue on the balance sheet as of December 31, 2025. Vaso reported record full-year 2025 revenue of $89.1 million (3% YoY growth) and net income of $1.6 million, holding $35.1 million in cash. It is publicly traded on the OTCQX tier under the ticker VASO.

Name

Vaso

Legal name

Vaso Corporation

Website

https://vasocorporation.com

Company type

Public

Founded year

1987

Operating status

Operating

Headcount range

251–500 employees

Short description

Vaso Corporation (OTC: VASO) is a diversified medical technology company that designs and sells proprietary EECP cardiovascular therapy systems and BIOX ambulatory monitoring devices through VasoMedical, serves as the exclusive U.S. sales representative for GE Healthcare diagnostic imaging equipment through VasoHealthcare, and delivers managed IT and network connectivity services through VasoTechnology, serving hospitals, clinics, and enterprises.

Ownership category

akta.pro rank

Product category

Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Mechanical Circulatory Support (VAD, IABP, ECMO) (HLAHAFAG)

akta.pro secondary industry

Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests) (CRADAMAK)

Keywords

• Medical devices
• Cardiovascular therapy
• Patient monitoring
• Diagnostic imaging
• Healthcare IT

Headquarters

HQ city

Plainview

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales and Service: VasoMedical generates revenue from the sale and service of proprietary EECP systems and BIOX monitoring equipment. Revenue includes equipment sales, equipment rentals, and service-related revenue from the growing installed base plus extended service contracts.
2. Professional Sales Representation Services: VasoHealthcare provides professional sales representation services for GE Healthcare diagnostic imaging equipment. Revenue is generated through sales commissions for capital medical equipment sales to healthcare facilities across the continental U.S.
3. Managed IT Services: VasoTechnology provides managed IT systems and services including healthcare software solutions and network connectivity services for enterprises and healthcare customers.
4. Extended Warranty and Service Contracts: Revenue from extended service contracts recognized ratably over the service period, typically one to four years. Deferred revenues associated with these contracts were $38.6 million as of December 31, 2025.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

Vaso Corporation designs, manufactures, sells, and services proprietary medical devices for non-invasive cardiovascular monitoring and treatment, including EECP therapy systems and BIOX ambulatory ECG Holter and blood pressure monitoring systems. Through its VasoHealthcare subsidiary, it provides professional sales representation services for GE Healthcare diagnostic imaging equipment to U.S. healthcare facilities, and through VasoTechnology, it delivers managed IT systems and network connectivity services to enterprises and healthcare customers.

Product overview

Vaso Corporation operates as a diversified medical technology company with three distinct business units. VasoMedical focuses on proprietary medical devices including EECP systems for cardiovascular treatment and BIOX series monitoring products. VasoHealthcare provides professional sales representation services for diagnostic imaging equipment, operating as a partner to GE Healthcare. VasoTechnology offers managed IT systems, network connectivity services, and healthcare software solutions through its NetWolves and VasoHealthcare IT brands. The company manufactures its EECP products through China-based facilities and maintains sales and service operations from US and China offices.

Differentiator

Problem solved

Functional benefit

Brands

• BIOX: Ambulatory ECG Holter and blood pressure monitoring systems
• EECP
• AngioNew
• Lumenair

Products and services

• EECP (Enhanced External Counterpulsation) Systems

Quantifiable outcome

• EECP therapy showed 35.4% of patients with NYHA Class II-III CHF achieved exercise duration increase of 60+ seconds compared to 25.3% control group (p=0.016) in PEECH clinical trial
• +2 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Two partnerships are on record, tiered minor and core.

• Nano-X Imaging Ltd.minorStrategic or Co-development Partner · 19 November 2025Vaso Corporation sold its subsidiary VasoHealthcare IT to Nano-X Imaging Ltd. in November 2025 for up to $800,000. This divestiture enabled Vaso to focus on its core operations and strategic initiatives. The sale was expected to be completed within a few weeks of the November 2025 announcement.
• GE HealthcarecoreChannel Partner/ Reseller/ Distributor · 1 January 2010VasoHealthcare (wholly owned subsidiary Vaso Diagnostics, Inc.) has been an exclusive sales representative for GE Healthcare diagnostic imaging equipment since 2010. The partnership was extended for the fifth time in December 2025 through December 31, 2030. VasoHealthcare specializes in diagnostic imaging modalities for healthcare's middle market including independent hospitals, imaging centers, and multispecialty clinics across the continental U.S.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• CompuMed: CompuMed provides remote cardiac monitoring and diagnostic services including ECG and Holter analysis; as a smaller emerging player it overlaps with BIOX ambulatory monitoring in the same cardiology channel with a services-led model.

Broad incumbents

• Medtronic: Medtronic is a dominant cardiovascular device manufacturer across heart failure, coronary, and rhythm management; its scale and clinical relationships compete indirectly with VasoMedical's EECP positioning in the cardiovascular treatment pathway.
• GE HealthCare: GE HealthCare is both VasoHealthcare's exclusive diagnostic imaging partner and a broad incumbent in medical imaging and patient monitoring; the partnership creates commercial overlap where GE's direct sales could substitute for Vaso's channel role.
• Koninklijke Philips: Philips is a broad incumbent in diagnostic imaging and ambulatory/cardiac monitoring, competing with both VasoHealthcare's imaging sales channel and VasoMedical's monitoring products across hospitals and ambulatory settings.
• Edwards Lifesciences: Edwards focuses on heart failure and structural heart disease with transcatheter heart valves and critical care monitoring; its heart failure franchise directly competes for the same cardiology budget and patient population targeted by EECP therapy.
• Baxter International (Hill-Rom): Baxter's Hill-Rom division offers a broad portfolio of patient monitoring, vital signs, and ambulatory diagnostic products that overlap with BIOX and broader VasoMedical hospital-monitoring offerings, though at much greater scale.
• Boston Scientific: Boston Scientific is a major cardiovascular device player offering interventional cardiology, peripheral vascular, and rhythm management solutions that occupy the same cardiologist customers Vaso serves through EECP and BIOX.
• Abbott: Abbott's cardiovascular and diagnostics franchises include cardiac monitoring, heart failure devices, and point-of-care diagnostics, intersecting with VasoMedical's therapeutic and diagnostic offerings and serving the same hospital customers.

Direct peers

• iRhythm Technologies: iRhythm is a direct competitor in ambulatory cardiac monitoring with its Zio long-term continuous ECG patch, directly comparable to VasoMedical's BIOX Holter/ABPM product line serving similar cardiology customers and reimbursement pathways.
• Spacelabs Healthcare (OSI Systems): Spacelabs manufactures cardiac Holter monitors, ambulatory ECG, and patient monitoring equipment that directly overlap with BIOX ambulatory monitoring products sold to hospitals and clinics for cardiovascular diagnosis.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xtwitter.com/vasomedical
• Facebookfacebook.com/vasomedical
• LinkedInlinkedin.com/company/vasomedical-inc

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vaso